T2 Biosystems, Inc. announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau. Under the terms of the agreement, T2 Biosystems will sell the T2Dx®? Instrument, the T2Bacteria Panel, the T2Candida Panel, and the T2Resistance Panel through the newly appointed distributor.

The execution of this exclusive distribution agreement further expands T2 Biosystems' commercialization in the Asia Pacific region. A 2023 study found that sepsis contributed to one in four adult deaths in Hong Kong. The study also found that adult sepsis incidence and mortality in Hong Kong has increased over the last decade.

A 2024 study found that detection rates of sepsis-causing Methicillin-Resistant Staphylococcus aureus (MRSA) has been higher in Macau than mainland China and Europe.